Gilloz A, Héritier P
Prog Clin Biol Res. 1984;162B:15-9.
In P3 P4 (N+ Mo) bladder cancer patients we conclude the following: 1) The addition of preoperative radiotherapy and meticulous pelvic cellulo-lymphadenectomy to total cystectomy has improved the actuarial survival at five years from 10.5% to 41%. 2) With this protocol, the pelvic recurrence has been reduced from 47.4% to 4.5% and presently the failures are due to undectectable distant metastases.
在P3 P4期(N+ Mo)膀胱癌患者中,我们得出以下结论:1)在全膀胱切除术中增加术前放疗和细致的盆腔细胞-淋巴结清扫术,已将5年实际生存率从10.5%提高到41%。2)采用该方案后,盆腔复发率从47.4%降至4.5%,目前治疗失败是由于无法检测到的远处转移。